ConductScience.org, home

Paper42707331

A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns.

Han B and 11 others. Ther Adv Hematol, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns. Papers, record 42707331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42707331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns.
PubMed
Journal
Ther Adv Hematol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-09
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Han BBing
2Liu HHuihttps://orcid.org/0000-0002-1969-6015
3He GGuangshenghttps://orcid.org/0000-0002-3944-5897
4Jia JJinsong
5Hong MMei
6Weng JJianyu
7Wang SShunqing
8Zhang FFengkui
9Niu TTing
10Ma TTianjun
11Xu JJinghan
12Fu RRonghttps://orcid.org/0000-0002-9928-9224

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06154512A Real-world, Multi-center, Prospective, Observational Study for PNH in ChinaDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138715220Advances in research on renal injury in paroxysmal nocturnal hemoglobinuria.J Investig Med2024https://conductscience.org/library/papers/38715220PubMed
230242915How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry.Eur J Haematol2019https://conductscience.org/library/papers/30242915PubMed
338071133Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape.Blood Rev2024https://conductscience.org/library/papers/38071133PubMed
430976687Appropriateness of red blood cell use in China in the last thirteen years: A systematic review.Heliyon2019https://conductscience.org/library/papers/30976687PubMed
539596172Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment.Int J Mol Sci2024https://conductscience.org/library/papers/39596172PubMed
621460245Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.Blood2011https://conductscience.org/library/papers/21460245PubMed
727059871A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America.Int J Hematol2016https://conductscience.org/library/papers/27059871PubMed
823271156Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.Clin Adv Hematol Oncol2012https://conductscience.org/library/papers/23271156PubMed
935390189
Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry.
Eur J Haematol2022https://conductscience.org/library/papers/35390189PubMed
1035068377Clinical characteristics of 512 eculizumab-naive paroxysmal nocturnal hemoglobinuria patients in China: a single-center observational study.Hematology2022https://conductscience.org/library/papers/35068377PubMed
1132390114Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.Ann Hematol2020https://conductscience.org/library/papers/32390114PubMed
1239882598Eculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety - a single-center study.Hematology2025https://conductscience.org/library/papers/39882598PubMed
1329486674Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment.Hematology2018https://conductscience.org/library/papers/29486674PubMed
1428516949Paroxysmal nocturnal haemoglobinuria.Nat Rev Dis Primers2017https://conductscience.org/library/papers/28516949PubMed
1534355382How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.Br J Haematol2022https://conductscience.org/library/papers/34355382PubMed
1618064739The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.Lancet2007https://conductscience.org/library/papers/18064739PubMed
1720658586Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.Am J Hematol2010https://conductscience.org/library/papers/20658586PubMed
1838442722Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry.J Korean Med Sci2024https://conductscience.org/library/papers/38442722PubMed
1938247114Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.Br J Haematol2024https://conductscience.org/library/papers/38247114PubMed
2027913482Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria.Hematology Am Soc Hematol Educ Program2016https://conductscience.org/library/papers/27913482PubMed

See all 28 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42707331

GET https://conductscience.org/api/papers/v1/42707331/references?page=2